Novavax (NVAX) Other Non Operating Income (2010 - 2026)

Novavax's Other Non Operating Income history runs 17 years deep, the most recent figure standing at $11.8 million for Q1 2026.

• On a quarterly basis, Other Non Operating Income rose 17.59% year-over-year to $11.8 million in Q1 2026; TTM through Mar 2026 was $42.4 million, a 42.82% decrease from a year earlier, with the FY2025 full-year figure at $40.6 million, changed 0.47% from the prior year.
• Other Non Operating Income climbed to $11.8 million in Q1 2026 per NVAX's latest filing, from $9.5 million in the prior quarter.
• Across five years, Other Non Operating Income topped out at $64.0 million in Q4 2022 and bottomed at -$34.8 million in Q3 2022.
• The 5-year median for Other Non Operating Income is $9.2 million (2025), against an average of $7.7 million.
• Biggest YoY gain for Other Non Operating Income was 14639.86% in 2022; the steepest drop was 756.31% in 2022.
• Year by year, Other Non Operating Income stood at $64.0 million in 2022, then plunged by 142.07% to -$26.9 million in 2023, then jumped by 250.27% to $40.4 million in 2024, then tumbled by 76.52% to $9.5 million in 2025, then gained by 24.51% to $11.8 million in 2026.
• Per Business Quant, the three latest NVAX Other Non Operating Income figures stand at $11.8 million (Q1 2026), $9.5 million (Q4 2025), and $9.2 million (Q3 2025).